DK0839149T3 - Galanthamin-derivater, fremgangsmåde til fremstilling deraf, anvendelse deraf som lægemidler og farmaceutiske præparater omfattende dem - Google Patents

Galanthamin-derivater, fremgangsmåde til fremstilling deraf, anvendelse deraf som lægemidler og farmaceutiske præparater omfattende dem

Info

Publication number
DK0839149T3
DK0839149T3 DK96926431T DK96926431T DK0839149T3 DK 0839149 T3 DK0839149 T3 DK 0839149T3 DK 96926431 T DK96926431 T DK 96926431T DK 96926431 T DK96926431 T DK 96926431T DK 0839149 T3 DK0839149 T3 DK 0839149T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical compositions
pct
pharmaceuticals
preparation
derivatives
Prior art date
Application number
DK96926431T
Other languages
English (en)
Inventor
Pierre Potier
Claude Thal
Catherine Guillou
Aude Mary
Dolor Renko
Yves Christen
Original Assignee
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient filed Critical Centre Nat Rech Scient
Application granted granted Critical
Publication of DK0839149T3 publication Critical patent/DK0839149T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK96926431T 1995-07-19 1996-07-19 Galanthamin-derivater, fremgangsmåde til fremstilling deraf, anvendelse deraf som lægemidler og farmaceutiske præparater omfattende dem DK0839149T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9514821.9A GB9514821D0 (en) 1995-07-19 1995-07-19 Galanthamine derivatives
PCT/FR1996/001139 WO1997003987A1 (fr) 1995-07-19 1996-07-19 Nouveaux derives de la galanthamine, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant

Publications (1)

Publication Number Publication Date
DK0839149T3 true DK0839149T3 (da) 2004-08-09

Family

ID=10777948

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96926431T DK0839149T3 (da) 1995-07-19 1996-07-19 Galanthamin-derivater, fremgangsmåde til fremstilling deraf, anvendelse deraf som lægemidler og farmaceutiske præparater omfattende dem

Country Status (16)

Country Link
US (1) US5958903A (da)
EP (1) EP0839149B9 (da)
JP (1) JP4177894B2 (da)
AT (1) ATE264332T1 (da)
AU (1) AU6662396A (da)
CA (1) CA2227235C (da)
DE (1) DE69632194T2 (da)
DK (1) DK0839149T3 (da)
ES (1) ES2218596T3 (da)
GB (1) GB9514821D0 (da)
IL (1) IL122739A0 (da)
MX (1) MX9800407A (da)
NO (1) NO980215L (da)
PT (1) PT839149E (da)
WO (1) WO1997003987A1 (da)
ZA (1) ZA966163B (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0104493A3 (en) * 1998-09-30 2002-12-28 Takeda Pharmaceutical Drugs for improving vesical excretory strength
WO2000030446A1 (en) 1998-11-23 2000-06-02 Bonnie Davis Dosage formulations for acetylcholinesterase inhibitors
EP1140105B1 (en) 1998-12-24 2003-10-22 Janssen Pharmaceutica N.V. Controlled release galantamine composition
WO2000041540A2 (en) * 1999-01-11 2000-07-20 Atanas Russinov Djananov Herbal supplement for increased muscle strength and endurance for athletes
US8603546B2 (en) * 1999-01-11 2013-12-10 Herbaceuticals Inc. Herbal supplement for increased muscle strength and endurance for athletes
US6372760B1 (en) * 1999-03-31 2002-04-16 Eisai Co., Ltd. Stabilized composition comprising antidementia medicament
CN1380883A (zh) * 2000-03-31 2002-11-20 萨诺化学药物股份公司 雪花胺的新衍生物和类似物
DE10129265A1 (de) * 2001-06-18 2003-01-02 Hf Arzneimittelforsch Gmbh Wirkstoff-Kombination zur medikamentösen Sucht- oder Rauschmitteltherapie
DE10134038A1 (de) * 2001-07-12 2003-02-06 Hf Arzneimittelforsch Gmbh Wirkstoff-Kombination zur medikamentösen Therapie der Nikotinabhängigkeit
WO2003080623A1 (de) * 2002-03-25 2003-10-02 Sanochemia Pharmazeutika Aktiengesellschaft Verfahren zur herstellung von norgalanthamin, ihren isomeren, salzen und hydraten
AT414125B (de) * 2003-09-29 2006-09-15 Sanochemia Pharmazeutika Ag Neue derivate des 4a,5,9,10,11,12-hexahydro- benzofuro(3a,3,2)(2) benzazepin, verfahren zu deren herstellung sowie deren verwendung zur herstellung von arzneimitteln
EP1667769A2 (de) * 2003-09-29 2006-06-14 Sanochemia Pharmazeutica Aktiengesellschaft Verwendung von galanthamin und seinen derivaten zum herstellen von arzneimitteln
US20050191349A1 (en) * 2003-12-31 2005-09-01 Garth Boehm Galantamine formulations
CA2552114A1 (en) * 2003-12-31 2005-07-21 Actavis Group Hf Solid dosage formulations of galantamine
DK1895994T3 (da) * 2005-05-13 2010-12-20 Alza Corp Multilagsmedikamentleveringssystem med barriere mod reservoirmaterialeflow
WO2007035941A2 (en) * 2005-09-23 2007-03-29 Alza Corporation Transdermal galantamine delivery system
JP5752598B2 (ja) 2008-09-11 2015-07-22 アイ．ビー．アール． イスラエリ バイオテクノロジー リサーチ リミテッド レウコユム球根の抽出物及びその利用
CN102573848A (zh) * 2009-04-24 2012-07-11 济州大学校产学协力团 含有去甲加兰他敏化合物作为活性成分的用于预防和治疗脱发症的组合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4663318A (en) * 1986-01-15 1987-05-05 Bonnie Davis Method of treating Alzheimer's disease
US4735169A (en) * 1986-09-03 1988-04-05 Nordson Corporation Adhesive applicator assembly
DE3856594D1 (de) * 1987-05-04 2008-11-27 Bonnie Davis Mittel zur behandlung der alzheimer-krankheit
US5336675A (en) * 1991-05-14 1994-08-09 Ernir Snorrason Method of treating mania in humans
US6323195B1 (en) * 1993-10-15 2001-11-27 Aventis Pharmaceuticals Inc. Galanthamine derivatives as acetylcholinesterase inhibitors
US5428159A (en) * 1994-04-08 1995-06-27 Ciba-Geigy Corporation Method of manufacture of (-)-galanthamine in high yield and purity substantially free of epigalanthamine

Also Published As

Publication number Publication date
GB9514821D0 (en) 1995-09-20
EP0839149B1 (fr) 2004-04-14
NO980215D0 (no) 1998-01-16
EP0839149A1 (fr) 1998-05-06
DE69632194D1 (de) 2004-05-19
EP0839149B9 (fr) 2005-03-09
ES2218596T3 (es) 2004-11-16
ATE264332T1 (de) 2004-04-15
US5958903A (en) 1999-09-28
MX9800407A (es) 1998-04-30
WO1997003987A1 (fr) 1997-02-06
CA2227235C (fr) 2010-08-31
NO980215L (no) 1998-01-16
CA2227235A1 (fr) 1997-02-06
JPH11509541A (ja) 1999-08-24
IL122739A0 (en) 1998-08-16
DE69632194T2 (de) 2005-03-17
JP4177894B2 (ja) 2008-11-05
AU6662396A (en) 1997-02-18
PT839149E (pt) 2004-08-31
ZA966163B (en) 1997-02-10

Similar Documents

Publication Publication Date Title
ZA973647B (en) Inhibitors of metalloprotease, process for preparing them and pharmaceutical compositions containing them.
NO980215L (no) Nye galantamin-derivater, fremgangsmåte for fremstilling derav, anvendelse derav som legemidler, og farmasöytiske blandinger inneholdende slike derivater
DK0477049T3 (da) 3-amido-pyrazolderivater, fremgangsmåde til deres fremstilling og farmaceutiske præparater indeholdende dem
NO981817D0 (no) Indolin-2-on-derivater, fremgangsmÕte for fremstilling av dem og farmas÷ytiske blandinger inneholdende dem
SG64372A1 (en) Rapamycin derivatives
AU6617596A (en) Cyclo-oxygenase inhibitor and amidine derivative salts, their preparation process, their use as medicaments, and pharmaceutical compositions containing them
PL314188A1 (en) Novel derivatives of benzoguanidine, method of obtaining them and their application in pharmaceutical compositions
NO975987D0 (no) 4-Fenylaminotiazol-derivater, fremgangsmåte for fremstilling av disse og farmasöytiske blandinger inneholdende nevnte derivater
FR2771291B1 (fr) Spheroides, procede de preparation et compositions pharmaceutiques
HUT70544A (en) Heteroaryl-amines as acetyl-cholinesterase inhibitors, pharmaceutical compositions comprising them and process for their preparation
DK0506539T3 (da) heterocykliske alkylamider, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
HUP9602635A3 (en) 4-aciloxy-benzenesulfonamide derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0002921A3 (en) Cyanoguanidines as cell proliferation inhibitors, process for producing them and pharmaceutical compositions containing them
NO955320D0 (no) Substituerte 4-fenyltiazolderivater, fremgangsmåte for fremstilling derav og farmasöytiske blandinger som inneholder dem
HUP9601062A3 (en) Chromone derivatives, pharmaceutical compositions containing them and process for their preparation
NO995685L (no) Nye glycosylerte ginkgolidderivater, anvendelse derav som medikamenter og farmasoeytiske blandinger
NO20006547L (no) Salter av paroxetine
NO20003290D0 (no) N-fenylamid- og N-pyridylamidderivater, fremgangsmÕte for fremstilling av dem, og farmasøytiske preparater som inneholder dem
NO20014803L (no) Pyrido-tieno-diazepiner, fremgangsmåte for fremstilling derav og farmasöytiske blandinger inneholdende dem
HUP9600173A2 (en) 4-amino-benzoyl-guanidine derivatives, process for preparing them and pharmaceutical compositions containing them
DK0776328T3 (da) 8-fluoranthracycliner, fremgangsmåder til fremstilling deraf og farmaceutiske præparater indeholdende dem
PL356523A1 (en) Substituted 1 and 2 naphthol mannich bases
NO952715D0 (no) Substituerte 1-(7-klor-4-kinoleinyl)pyrazol-3-karboksamid-N-oksyd-derivater, fremgangsmåte ved fremstilling derav og farmasöytiske preparater som inneholder dem
NO995905D0 (no) Nye fencyclidinderivater, fremgangsmåter for fremstilling og farmasöytiske blandinger som inneholder disse